telehealth glp-1 crackdown news Beth Siemer and Brian Malkin Analyze FDA on Compounding and in Pharmacy Times FDA Targets Telehealth Compounded GLP-1

Yes, tirzepatide is approved for type 2 diabetes management

Human users have reported occasional headaches, mild GI discomfort, and transient fatigue

Tresiba is only part of a complete treatment program that may also include diet, exercise, weight control, regular blood sugar testing, and special medical care

however, active legal challenges have currently suspended enforcement, meaning access through licensed providers remains possible

Given the high demand and the complex and rapidly changing coverage environment, patients, providers, advocates, and policymakers are seeking better information about the insurance coverage landscape